These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26885366)

  • 41. Immune approaches to the treatment of breast cancer, around the corner?
    Criscitiello C; Esposito A; Gelao L; Fumagalli L; Locatelli M; Minchella I; Adamoli L; Goldhirsch A; Curigliano G
    Breast Cancer Res; 2014 Feb; 16(1):204. PubMed ID: 25774617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity.
    Ramsay AG
    Br J Haematol; 2013 Aug; 162(3):313-25. PubMed ID: 23691926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
    Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer immunotherapy: accomplishments to date and future promise.
    Helmy KY; Patel SA; Nahas GR; Rameshwar P
    Ther Deliv; 2013 Oct; 4(10):1307-20. PubMed ID: 24116914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.
    Miyahira AK; Kissick HT; Bishop JL; Takeda DY; Barbieri CE; Simons JW; Pienta KJ; Soule HR
    Prostate; 2015 Mar; 75(4):337-47. PubMed ID: 25358693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy.
    Cruz-Bermúdez A; Laza-Briviesca R; Casarrubios M; Sierra-Rodero B; Provencio M
    Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33807260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anthracyclines potentiate anti-tumor immunity: A new opportunity for chemoimmunotherapy.
    Zhang Z; Yu X; Wang Z; Wu P; Huang J
    Cancer Lett; 2015 Dec; 369(2):331-5. PubMed ID: 26454214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Next generation of immunotherapy for melanoma.
    Kirkwood JM; Tarhini AA; Panelli MC; Moschos SJ; Zarour HM; Butterfield LH; Gogas HJ
    J Clin Oncol; 2008 Jul; 26(20):3445-55. PubMed ID: 18612161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.
    Isidori A; Salvestrini V; Ciciarello M; Loscocco F; Visani G; Parisi S; Lecciso M; Ocadlikova D; Rossi L; Gabucci E; Clissa C; Curti A
    Expert Rev Hematol; 2014 Dec; 7(6):807-18. PubMed ID: 25227702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune disorder in endometrial cancer: Immunosuppressive microenvironment, mechanisms of immune evasion and immunotherapy.
    Zhan L; Liu X; Zhang J; Cao Y; Wei B
    Oncol Lett; 2020 Sep; 20(3):2075-2090. PubMed ID: 32782525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment.
    Shan Y; Ni Q; Zhang Q; Zhang M; Wei B; Cheng L; Zhong C; Wang X; Wang Q; Liu J; Zhang J; Wu J; Wang G; Zhou F
    Acta Pharm Sin B; 2022 Apr; 12(4):1825-1839. PubMed ID: 35847509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial Control and Guidance of Cellular Activities of T Cells.
    Chao T; Wang H; Ho PC
    Front Immunol; 2017; 8():473. PubMed ID: 28484465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T Cell Metabolism in Cancer Immunotherapy.
    Aksoylar HI; Tijaro-Ovalle NM; Boussiotis VA; Patsoukis N
    Immunometabolism; 2020; 2(3):. PubMed ID: 32642279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.
    Laderach DJ; Compagno D
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Curcumin as an Adjuvant to Cancer Immunotherapy.
    Paul S; Sa G
    Front Oncol; 2021; 11():675923. PubMed ID: 34485117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion.
    Gan LL; Hii LW; Wong SF; Leong CO; Mai CW
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring Non-Metabolic Functions of Glycolytic Enzymes in Immunity.
    Seki SM; Gaultier A
    Front Immunol; 2017; 8():1549. PubMed ID: 29213268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sugar or Fat?-Metabolic Requirements for Immunity to Viral Infections.
    Shehata HM; Murphy AJ; Lee MKS; Gardiner CM; Crowe SM; Sanjabi S; Finlay DK; Palmer CS
    Front Immunol; 2017; 8():1311. PubMed ID: 29085369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.